• Uterine carcinosarkoma: stages of diagnosis and treatment 

Uterine carcinosarkoma: stages of diagnosis and treatment 

HEALTH OF WOMAN. 2016.4(110):156–159; doi 10.15574/HW.2016.110.156 
 

Uterine carcinosarkoma: stages of diagnosis and treatment 
 

Symonchuk E. V., Sharma N. A.

National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev 
 

The article presents data on clinical and morphological features of carcinosarcoma and uterine adenocarcinoma; examined diagnostics, especially surgery to the treatment, the efficacy of adjuvant radiation and chemotherapy, follow-up. 
 

Key words: carcinosarcoma uterine adenocarcinoma, diagnosis, treatment. 
 

REFERENCES

1.Bohman YV, Urmancheeva AF. 1996. Uterine sarcoma. St. Petersburg, Hippocrates:128.

2. Urmancheeva AF, Kutusheva GF, Ulrich EА. 2006. Sarcomas female genitals. Diagnostics and treatment. Clinical Oncology (selected lectures). in 2 Vol., Publishing House. St. Petersburg:127-143.

3. Lazareva NI, Kuznetsov VV, Zakharova TI. 2005. Sarcoma. Clinical Oncology: Guide for Physicians. M.: Publishing House. Medicine:178-219.

4. FIGO Committee on Gynecologic Oncology. 2009. FIGO staging for uterine sarcomas. J. Gynaecol. Obstet. 104:179.

5. Hensley ML. 2006. Uterine sarcomas and carcinosarcomas: advances for advanced disease and updates on adjuvant therapy. ASCO Educational Book:301–304.

6. Homesley HD, Filiaci V, Markman M, Bitterman P, Eaton L, Kilgore LC, Monk BJ, Ueland FR. 2007. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol. 25:526–531. http://dx.doi.org/10.1200/JCO.2006.06.4907; PMid:17290061

7. Hoskins PJ, Le N, Ellard S, Lee U, Martin LA, Swenerton KD, Tinker AV. 2008. British Columbia Cancer Agency Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. Gynecol Oncol. 108:58–62. http://dx.doi.org/10.1016/j.ygyno.2007.08.084http://dx.doi.org/10.1097/01.ogx.0000310472.86484.ca

8. Kawaguchi W, Itamochi H, Kigawa J, Kanamori Y, Oishi T, Shimada M, Sato S, Sato S, Terakawa N. 2008. Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed mullerian tumor of the fallopian tube. Int J Clin Oncol. 13:461–463. http://dx.doi.org/10.1007/s10147-008-0767-1; PMid:18946759

9. McCluggage WG. 2002. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas. J. Clin. Pathol. 55(5):460-469. http://dx.doi.org/10.1136/jcp.55.5.321

10. Pectasides D, Pectasides E, Papaxoinis G, Xiros N, Sykiotis C, Papachristodoulou A, Tountas N, Panayiotides J, Economopoulos T. 2008. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution. Gynecol Oncol. 110:299–303. http://dx.doi.org/10.1016/j.ygyno.2008.05.017; PMid:18602677

11. Petru E, Jonat W, Fink D, Kochli O. 2009. Praxisbuch Gynakologische Onklogie. Springer. Heidelberg:54-58. http://dx.doi.org/10.1007/978-3-540-78327-5

12. Powell MA, Filiaci VL, Rose PG, Mannel RS, Hanjani P, Degeest K, Miller BE, Susumu N, Ueland FR. 2010. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. J Clin Oncol. 28:2727–2731. http://dx.doi.org/10.1200/JCO.2009.26.8326; PMid:20421537 PMCid:PMC2881851

13. Ramondetta LM, Lacour RA, Euscher ED, Iyer RB, Atkinson EN, Gano JB, Milam MR, Ramirez PT, Levenback CF, Burke TW. 2007. Рhase II multicenter trial of paclitaxel and carboplatin in women with advanced or recurrent malignant mixed mullerian tumors (MMMT) of the uterus. J Clin Oncol. 2518.

14. Sutton G, Brunetto VL, Kilgore L, Soper JT, McGehee R, Olt G, Lentz SS, Sorosky J, Hsiu JG. 2000. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study. Gynecol Oncol. 79:147–153. http://dx.doi.org/10.1006/gyno.2000.6001; PMid:11063636

15. Sutton G, Kauderer J, Carson LF, Lentz SS, Whitney CW, Gallion H. 2005. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol. 96:630–634. http://dx.doi.org/10.1016/j.ygyno.2004.11.022; PMid:15721404

16. Thigpen JT, Blessing JA, Beecham J, Homesley H, Yordan E. 1991. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol. 9:1962–1966.

17. Toyoshima M, Akahira J, Matsunaga G, Niikura H, Ito K, Yaegashi N, Tase T. 2004. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. Gynecol Oncol. 94:774–778. http://dx.doi.org/10.1016/j.ygyno.2004.05.048; PMid:15350372